Literature DB >> 8311449

Identification of calbindin D-9k mRNA and its regulation by 1,25-dihydroxyvitamin D3 in Caco-2 cells.

J C Fleet1, R J Wood.   

Abstract

We have identified and quantified specific mRNAs in the human colonic carcinoma cell line Caco-2 by reverse transcriptase-polymerase chain reaction. Initial examination revealed that like rat duodenal mucosa, Caco-2 cells possessed mRNA for the vitamin D receptor. Using primers for human calbindin we found a 237-bp PCR product in Caco-2 cell RNA, but not from rat duodenal RNA. Primers for rat calbindin did not amplify calbindin mRNA in Caco-2 RNA, confirming a high degree of mismatch between rat and human sequences. 1,25(OH)2 vitamin D3 treatment (10 nM) significantly elevated calbindin mRNA levels 50% by 12 h, with maximal levels occurring by 48 h (fivefold elevation). Increasing concentrations of 1,25(OH)2 vitamin D3 (from 15 pM to 100 nM) caused progressive increases in calbindin mRNA levels following 48 h of treatment. Elevated calbindin mRNA levels were associated with enhancement of transcellular calcium transport. Our results are the first demonstration of vitamin D-regulated calbindin mRNA in a human intestinal cell line.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8311449     DOI: 10.1006/abbi.1994.1024

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Evidence for a role of prolactin in calcium homeostasis: regulation of intestinal transient receptor potential vanilloid type 6, intestinal calcium absorption, and the 25-hydroxyvitamin D(3) 1alpha hydroxylase gene by prolactin.

Authors:  Dare V Ajibade; Puneet Dhawan; Adam J Fechner; Mark B Meyer; J Wesley Pike; Sylvia Christakos
Journal:  Endocrinology       Date:  2010-05-12       Impact factor: 4.736

2.  Factors involved in the duodenal expression of the human calbindin-D9k gene.

Authors:  N F Barley; S R Prathalingam; P Zhi; S Legon; A Howard; J R Walters
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

3.  Effect of 17beta-oestradiol on transepithelial calcium transport in human intestinal-like Caco-2 cells and its interactions with 1,25-dihydroxycholecalciferol and 9-cis retinoic acid.

Authors:  A A Cotter; Kevin D Cashman
Journal:  Eur J Nutr       Date:  2006-02-20       Impact factor: 5.614

4.  The effect of differentiation on 1,25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2.

Authors:  Min Cui; Anna Klopot; Yan Jiang; James C Fleet
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

5.  Control of differentiation-induced calbindin-D9k gene expression in Caco-2 cells by cdx-2 and HNF-1alpha.

Authors:  Liyong Wang; Anna Klopot; Jean-Noel Freund; Lauren N Dowling; Stephen D Krasinski; James C Fleet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-06-24       Impact factor: 4.052

6.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line.

Authors:  R J Wood; L Tchack; S Taparia
Journal:  BMC Physiol       Date:  2001-08-17

7.  Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia.

Authors:  Santosh A Khedkar; Mohammed A Samad; Sangita Choudhury; Ji Yoo Lee; Dongsheng Zhang; Ravi I Thadhani; S Ananth Karumanchi; Alan C Rigby; Peter M Kang
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

8.  Glycocholic acid and butyrate synergistically increase vitamin D-induced calcium uptake in Caco-2 intestinal epithelial cell monolayers.

Authors:  Anna Casselbrant; Lars Fändriks; Ville Wallenius
Journal:  Bone Rep       Date:  2020-07-03

9.  Endocrine disruption of vitamin D activity by perfluoro-octanoic acid (PFOA).

Authors:  Andrea Di Nisio; Maria Santa Rocca; Luca De Toni; Iva Sabovic; Diego Guidolin; Stefano Dall'Acqua; Laura Acquasaliente; Vincenzo De Filippis; Mario Plebani; Carlo Foresta
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.